What is the current Price Target for the ARCA biopharma, Inc. stock?

The average ARCA biopharma, Inc. target price is $43.86. This is 58.05% higher than the current stock price. The highest price target is 111.89%, the lowest is -5.37%. 12 Analysts have issued a price target ARCA biopharma, Inc. 2026 .

How high will the ARCA biopharma, Inc. stock rise?

No reliable answer can be given as to how high the ARCA biopharma, Inc. stock will rise. The performance of stocks, including the ARCA biopharma, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ARCA biopharma, Inc. stock today?

The performance of ARCA biopharma, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ARCA biopharma, Inc. stock fall?

The decline in ARCA biopharma, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ARCA biopharma, Inc. Forecast, price target & analysts

$27.75

1.87% yesterday

Nasdaq, Nov 07, 10:00 pm CET

ISIN

US00211Y4070

Symbol

ORKA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

ARCA biopharma, Inc. Target price 2025 - Analyst rating & recommendation

ARCA biopharma, Inc. Classifications & Recommendation:

Buy

94%

Hold

ARCA biopharma, Inc. Price Target

Target Price	$43.86
Price	$27.75
Potential	58.05% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target ARCA biopharma, Inc. 2026 . The average ARCA biopharma, Inc. target price is $43.86. This is 58.05% register free of charge higher than the current stock price. The highest price target is $58.80 111.89% register free of charge , the lowest is $26.26 5.37% register free of charge .
	A rating was issued by 18 analysts: 17 Analysts recommend ARCA biopharma, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ARCA biopharma, Inc. stock has an average upside potential 2026 of 58.05% register free of charge . Most analysts recommend the ARCA biopharma, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-4.99	-2.25
	12.39%	54.91%
P/E		negative

12 Analysts have issued a ARCA biopharma, Inc. forecast for earnings per share. The average ARCA biopharma, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.99	12.39%
2025	$-2.25 54.91% Unlock
2026	$-2.57 14.22% Unlock
2027	$-2.83 10.12% Unlock

Current	-11.93	78.18%
2025	-12.56 5.26% Unlock
2026	-11.01 12.34% Unlock
2027	-10.01 9.08% Unlock

ARCA biopharma, Inc....

Current ARCA biopharma, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Oct 27 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 27 2025
Barclays	Locked ➜ Locked	Locked	Oct 13 2025
BTIG	Locked ➜ Locked	Locked	Sep 29 2025
BTIG	Locked ➜ Locked	Locked	Sep 17 2025
Clear Street	Locked ➜ Locked	Locked	Sep 17 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 18 2025

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Oct 27 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 27 2025
Locked Barclays: Locked ➜ Locked	Oct 13 2025
Locked BTIG: Locked ➜ Locked	Sep 29 2025
Locked BTIG: Locked ➜ Locked	Sep 17 2025
Locked Clear Street: Locked ➜ Locked	Sep 17 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 18 2025

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now